Ratnamani Metals gains on order win
Ratnamani Metals gains on order win

Ratnamani Metals gains on order win

Nidhi Jani Article rating: 4.3

The company’s order book as on Q3FY19 stood at Rs. 1,322 crore. The order book split up stood at Carbon Steel (69 per cent) and high margin stainless steel (31 per cent).

Market Close: Sensex posts 249 points gain
Market Close: Sensex posts 249 points gain

Market Close: Sensex posts 249 points gain

Gayathri Udyawar Article rating: 5.0

Markets were upbeat throughout the day on Monday. Initially, post the pre-market session, the markets had dipped, but they soon gained momentum and continued the upward rally. The BSE Sensex closed with 0.63 per cent gains. Mid-cap stocks joined the rally with RBL up 19 per cent and ABB and IGL posting around 10 per cent gains.

Overnight Digest: Stocks to watch out on May 28
Overnight Digest: Stocks to watch out on May 28

Overnight Digest: Stocks to watch out on May 28

Shohini Nath Article rating: 5.0

The stocks that are likely to witness significant movement on the bourses on May 28 are Colgate Palmolive, Brigade Enterprises, NIIT Technologies, Sterlite Technologies and Ratnamani Metals & Tubes.

Ten stocks close to their 52-weeks high
Ten stocks close to their 52-weeks high

Ten stocks close to their 52-weeks high

Shital Jibhe Article rating: 5.0

The markets on May 27, 2019 opened up. BSE Sensex is trading at 39,670.59, up by 235.87 points and the Nifty is trading at 11,924.60, up by 80.50 points. 

Should you buy guaranteed monthly income plan from insurers?
Should you buy guaranteed monthly income plan from insurers?

Should you buy guaranteed monthly income plan from insurers?

Henil Shah Article rating: 3.0

Insurance is a product which helps in covering your risk in life. However, there are plans which provide you with guaranteed monthly income. So, should you go for such plans? Let’s find out.

Granules India up 2 per cent on USFDA approval
Granules India up 2 per cent on USFDA approval

Granules India up 2 per cent on USFDA approval

Nidhi Jani Article rating: 3.6

Methylphenidate hydrochloride extended-release capsules are used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD). The company has submitted a total 19 ANDAs out of which 16 are waiting for approval.

RSS
First31953196319731983200320232033204Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR